Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona

被引：0
作者：
Xavier Solanich
Raúl Rigo-Bonnin
Victor-David Gumucio
Paul Bastard
Jérémie Rosain
Quentin Philippot
Xosé-Luis Perez-Fernandez
Maria-Paz Fuset-Cabanes
Miguel-Ángel Gordillo-Benitez
Guillermo Suarez-Cuartin
Enric Boza-Hernandez
Antoni Riera-Mestre
Alba Parra-Martínez
Roger Colobran
Arnau Antolí
Sergio Navarro
Gemma Rocamora-Blanch
Mario Framil
Laura Calatayud
Xavier Corbella
Jean-Laurent Casanova
Francisco Morandeira
Joan Sabater-Riera
机构：
[1] Hospital Universitari de Bellvitge,Department of Internal Medicine
[2] L’Hospitalet de Llobregat,Department of Clinical Laboratory
[3] Bellvitge Biomedical Research Institute (IDIBELL),Department of Intensive Care
[4] L’Hospitalet de Llobregat,Laboratory of Human Genetics of Infectious Diseases, Necker Branch
[5] Hospital Universitari de Bellvitge,Imagine Institute
[6] L’Hospitalet de Llobregat,St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch
[7] Hospital Universitari de Bellvitge,Department of Respiratory Medicine
[8] L’Hospitalet de Llobregat,Department of Anesthesiology
[9] INSERM U1163,Faculty of Medicine and Health Sciences
[10] Necker Hospital for Sick Children,Infection in Immunocompromised Pediatric Patients Research Group
[11] University of Paris,Pediatric Infectious Diseases and Immunodeficiencies Unit
[12] The Rockefeller University,Immunology Division, Genetics Department
[13] Hospital Universitari de Bellvitge,Diagnostic Immunology Research Group
[14] L’Hospitalet de Llobregat,Immunology Unit. Department of Cellular Biology, Physiology and Immunology
[15] Hospital Universitari de Bellvitge,Department of Immunology
[16] L’Hospitalet de Llobregat,Department of Microbiology
[17] Universitat de Barcelona,School of Medicine
[18] Vall d’Hebron Institut de Recerca (VHIR),undefined
[19] Vall d’Hebron Barcelona Hospital Campus,undefined
[20] Hospital Universitari Vall d’Hebron,undefined
[21] Vall d’Hebron Barcelona Hospital Campus,undefined
[22] Hospital Universitari Vall d’Hebron,undefined
[23] Vall d’Hebron Barcelona Hospital Campus,undefined
[24] Vall d’Hebron Institut de Recerca (VHIR),undefined
[25] Vall d’ Hebron Barcelona Hospital Campus,undefined
[26] Universitat Autònoma de Barcelona (UAB),undefined
[27] Hospital Universitari de Bellvitge,undefined
[28] L’Hospitalet de Llobregat,undefined
[29] Hospital Universitari de Bellvitge,undefined
[30] L’Hospitalet de Llobregat,undefined
[31] Universitat Internacional de Catalunya,undefined
[32] Howard Hughes Medical Institute,undefined
来源：
Journal of Clinical Immunology | 2021年 / 41卷
关键词：
COVID-19; SARS-CoV-2; acute kidney injury; type I interferons; auto-antibodies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1733 / 1744
页数：11
相关论文
共 144 条
  • [1] Lai CC(2020)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges Int J Antimicrob Agents 17 1123-1138
  • [2] Shih TP(2020)Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence Int J Antimicrob Agents 19 14-20
  • [3] Ko WC(2020)Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications Eur J Epidemiol 35 290-297
  • [4] Tang HJ(2020)Life-threatening COVID-19: defective interferons unleash excessive inflammation Med (N Y) 1 497-506
  • [5] Hsueh PR(2020)Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness Int J Infect Dis 101 934-943
  • [6] Wang L(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 910-941
  • [7] Wang Y(2020)Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China JAMA Intern Med 180 40-3
  • [8] Ye D(2020)Immunology of COVID-19: current state of the science Immunity 52 27-9
  • [9] Liu Q(2020)Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity Hum Genomics 14 eabd4570-288
  • [10] Levin AT(2021)COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy Hum Genomics 15 eabd4585-3
12345678910